301122 采纳股份
已收盘 05-17 15:00:00
资讯
新帖
简况
环龙控股(02260)采纳股份奖励计划
智通财经 · 05-09
环龙控股(02260)采纳股份奖励计划
光尚文化控股公布批准采纳股份奖励计划
新浪港股 · 05-03
光尚文化控股公布批准采纳股份奖励计划
光尚文化控股(08082):批准采纳股份奖励计划
智通财经网 · 05-02
光尚文化控股(08082):批准采纳股份奖励计划
采纳股份(301122)2024年一季报简析:营收净利润同比双双增长
证券之星 · 04-26
采纳股份(301122)2024年一季报简析:营收净利润同比双双增长
采纳股份(301122.SZ)发布2023年度业绩,净利润1.13亿元,下降30.46%
智通财经网 · 04-18
采纳股份(301122.SZ)发布2023年度业绩,净利润1.13亿元,下降30.46%
采纳股份跌15.14% 2022年上市超募7亿海通证券保荐
中国经济网 · 04-08
采纳股份跌15.14% 2022年上市超募7亿海通证券保荐
采纳股份3月18日现17笔大宗交易 成交金额6811.28万元
智能小浪 · 03-18
采纳股份3月18日现17笔大宗交易 成交金额6811.28万元
采纳股份(301122.SZ)子公司营养转接头产品通过美国FDA审核
智通财经网 · 01-22
采纳股份(301122.SZ)子公司营养转接头产品通过美国FDA审核
海通证券保荐采纳股份IPO项目质量评级C级 发行市盈率高出行业均值近1倍 超募7亿元比例高达141.69%
新浪证券 · 2023-12-26
海通证券保荐采纳股份IPO项目质量评级C级 发行市盈率高出行业均值近1倍 超募7亿元比例高达141.69%
加载更多
公司概况
公司名称:
采纳科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2022-01-26
主营业务:
采纳科技股份有限公司主营业务为从事注射穿刺器械及实验室耗材的研发、生产和销售。公司目前主要产品为医疗器械、动物器械、实验室耗材等。公司被认定为2022年度江苏省专精特新中小企业。
发行价格:
50.31
{"stockData":{"symbol":"301122","market":"SZ","secType":"STK","nameCN":"采纳股份","latestPrice":22.56,"timestamp":1715929380000,"preClose":22.46,"halted":0,"volume":1442210,"delay":0,"floatShares":44245700,"shares":122000000,"eps":0.9958,"marketStatus":"已收盘","marketStatusCode":5,"change":0.1,"latestTime":"05-17 15:00:00","open":22.43,"high":22.82,"low":22.35,"amount":32476500,"amplitude":0.0209,"askPrice":22.58,"askSize":7,"bidPrice":22.56,"bidSize":13,"shortable":0,"etf":0,"ttmEps":0.9958,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"adjPreClose":22.46,"symbolType":"stock","openAndCloseTimeList":[[1715909400000,1715916600000],[1715922000000,1715929200000]],"highLimit":24.71,"lowLimit":20.21,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":122245658,"pbRate":1.5,"roa":"--","roe":"1.38%","epsLYR":0.92,"committee":0.5,"marketValue":2758000000,"floatMarketCap":998000000,"peRate":22.655151,"changeRate":0.0045,"turnoverRate":0.0326,"status":0},"requestUrl":"/m/hq/s/301122","defaultTab":"news","newsList":[{"id":"2434061011","title":"环龙控股(02260)采纳股份奖励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2434061011","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2434061011?lang=zh_cn&edition=full","pubTime":"2024-05-09 17:56","pubTimestamp":1715248578,"startTime":"0","endTime":"0","summary":"智通财经APP讯,环龙控股(02260)发布公告,该公司于2024年5月9日采纳股份奖励计划,经董事会挑选的合资格参与者(不包括除外参与者)可参与股份奖励计划。采纳股份奖励计划旨在:认可若干合资格参与者对集团增长及发展所作贡献及就此奖励该等合资格参与者;及为集团的进一步发展吸引合适人士。根据股份奖励计划可授出的股份数目上限不得超过3000万股,即该公司于采纳日期已发行股本的约6.21%。根据股份奖励计划可授出予一名选定参与者的奖励股份数目上限不得超过该公司不时已发行股本的1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1119347.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432963462","title":"光尚文化控股公布批准采纳股份奖励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2432963462","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2432963462?lang=zh_cn&edition=full","pubTime":"2024-05-03 06:26","pubTimestamp":1714688760,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 光尚文化控股(08082)发布公告,根据股东特别大会的投票结果及GEM上市规则第23.02(1)条,有关批准采纳股份奖励计划;及终止现行购股权计划及采纳新购股权计划的普通决议案以投票方式获正式通过。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-05-03/doc-inatwxhm6829890.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-05-03/doc-inatwxhm6829890.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432835989","title":"光尚文化控股(08082):批准采纳股份奖励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2432835989","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2432835989?lang=zh_cn&edition=full","pubTime":"2024-05-02 22:57","pubTimestamp":1714661853,"startTime":"0","endTime":"0","summary":"光尚文化控股(08082)发布公告,根据股东特别大会的投票结果及GEM上市规则第2...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_23.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_23.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116982.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430263106","title":"采纳股份(301122)2024年一季报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2430263106","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430263106?lang=zh_cn&edition=full","pubTime":"2024-04-26 06:31","pubTimestamp":1714084304,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期采纳股份发布2024年一季报。根据财报显示,本报告期中采纳股份营收净利润同比双双增长。截至本报告期末,公司营业总收入1.11亿元,同比上升65.52%,归母净利润2504.54万元,同比上升57.73%。公司最新一期年度报表的现金流为正,经营性现金流和利润稍微不匹配,问题不大。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600014063.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428594875","title":"采纳股份(301122.SZ)发布2023年度业绩,净利润1.13亿元,下降30.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428594875","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2428594875?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:20","pubTimestamp":1713446400,"startTime":"0","endTime":"0","summary":"采纳股份(301122.SZ)发布2023年年度报告,该公司营业收入为4.1亿元,同比减少11.82%。归属于上市公司股东的净利润为1.13亿元,同比减少30.46%。归属于上市公司股东的扣除非经常性损益的净利润为8485.8万元,同比减少38.98%。基本每股收益为0.92元。报告期内,公司通过强化组织建设,深化经营管理,优化运营安排,持续发挥高效研发体系、新产品持续推出。此外,拟向全体股东每10股派发现金红利4.00元(含税)。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-18/doc-inashhku6282253.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-18/doc-inashhku6282253.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425957009","title":"采纳股份跌15.14% 2022年上市超募7亿海通证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2425957009","media":"中国经济网","top":-1,"share":"https://www.laohu8.com/m/news/2425957009?lang=zh_cn&edition=full","pubTime":"2024-04-08 16:49","pubTimestamp":1712566140,"startTime":"0","endTime":"0","summary":"中国经济网北京4月8日讯采纳股份 今日股价收报22.48元,下跌15.14%,总市值27.48亿元。 2022年1月26日,采纳股份在深交所创业板上市,公开发行股票2350.88万股,为发行后总股本的25.00%,发行价格为50.31元/股,保荐机构为海通证券股份有限公司,保荐代表人为钟祝可、张刚。 采纳股份本次发行费用总额8546.53万元,海通证券股份有限公司获得承销保荐费用7252.58万元。 采纳股份2023年5月10日公告分红方案,每10股派息(税前)4.5元,转增3股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-04-08/doc-inarchuu4126228.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-04-08/doc-inarchuu4126228.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2420476594","title":"采纳股份3月18日现17笔大宗交易 成交金额6811.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420476594","media":"智能小浪","top":-1,"share":"https://www.laohu8.com/m/news/2420476594?lang=zh_cn&edition=full","pubTime":"2024-03-18 17:00","pubTimestamp":1710752400,"startTime":"0","endTime":"0","summary":" 3月18日,采纳股份收涨1.40%,收盘价为30.45元,发生17笔大宗交易,合计成交量243.26万股,成交金额6811.28万元。 第11笔成交价格为28.00元,成交16.00万股,成交金额448.00万元,溢价率为-8.05%,买方营业部为国都证券股份有限公司江苏分公司,卖方营业部为机构专用。 进一步统计,近3个月内该股累计发生17笔大宗交易,合计成交金额为6811.28万元。该股近5个交易日累计上涨6.73%,主力资金合计净流出235.8万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-03-18/doc-inantvpn5367905.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-03-18/doc-inantvpn5367905.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2405942184","title":"采纳股份(301122.SZ)子公司营养转接头产品通过美国FDA审核","url":"https://stock-news.laohu8.com/highlight/detail?id=2405942184","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2405942184?lang=zh_cn&edition=full","pubTime":"2024-01-22 16:16","pubTimestamp":1705911360,"startTime":"0","endTime":"0","summary":"采纳股份(301122.SZ)公告,公司全资子公司江苏采纳医疗科技有限公司(简称“采纳医疗”)于近日收到美国食品药品监督管理局(简称“FDA”)的通知,采纳医疗的营养转接头产品通过美国FDA的审核,正式获得美国市场准入许可。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-22/doc-inaekwze4298839.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-22/doc-inaekwze4298839.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2394119542","title":"海通证券保荐采纳股份IPO项目质量评级C级 发行市盈率高出行业均值近1倍 超募7亿元比例高达141.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2394119542","media":"新浪证券","top":-1,"share":"https://www.laohu8.com/m/news/2394119542?lang=zh_cn&edition=full","pubTime":"2023-12-26 16:08","pubTimestamp":1703578080,"startTime":"0","endTime":"0","summary":" 采纳股份承销保荐佣金率为6.13%,高于整体平均数5.19%,低于保荐人海通证券2022年度IPO承销项目平均佣金率6.86%。 上市首日涨幅44.03%。 采纳股份的发行市盈率为83.85倍,行业均数42.2倍,公司高于行业98.70%。 预计募资4.89亿元,实际募资11.83亿元,超募比例141.69%。 采纳股份IPO项目总得分为74.5分,分类C级。影响采纳股份评分负面因素是:公司信披质量待提高,发行费用率较高,发行市盈率较高,超募比例较高。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/observe/2023-12-26/doc-imzzisvv9691696.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2023-12-26/doc-imzzisvv9691696.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-01-26","address":"江苏省无锡市江阴市华士镇澄鹿路253号","stockEarnings":[{"period":"1week","weight":-0.0569},{"period":"1month","weight":0.0287},{"period":"3month","weight":-0.0896},{"period":"6month","weight":-0.457},{"period":"1year","weight":-0.3207},{"period":"ytd","weight":-0.3337}],"companyName":"采纳科技股份有限公司","boardCode":"AI0035","perCapita":"5755股","boardName":"专用设备制造业","registeredCapital":"12224万元","compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.0326},{"period":"1year","weight":-0.0435},{"period":"ytd","weight":0.0602}],"survey":" 采纳科技股份有限公司主营业务为从事注射穿刺器械及实验室耗材的研发、生产和销售。公司目前主要产品为医疗器械、动物器械、实验室耗材等。公司被认定为2022年度江苏省专精特新中小企业。","serverTime":1716122605335,"listedPrice":50.31,"stockholders":"7688人(较上一季度增加2.90%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"采纳股份(301122)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供采纳股份(301122)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"采纳股份,301122,采纳股份股票,采纳股份股票老虎,采纳股份股票老虎国际,采纳股份行情,采纳股份股票行情,采纳股份股价,采纳股份股市,采纳股份股票价格,采纳股份股票交易,采纳股份股票购买,采纳股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"采纳股份(301122)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供采纳股份(301122)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}